As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: February 23, 2012
by Crystal Phend for MedPage Today
A compound found in oranges, grapefruit, and other citrus fruit may modestly reduce stroke risk among women, an observational study determined.
Women with the highest levels of flavanone in their diet were 19% less likely to have an ischemic stroke during 14 years of follow-up than those with the least flavanone intake (P=0.04), Aedín Cassidy, PhD, of the University of East Anglia in Norwich, England, and colleagues found.
As the main source of these antioxidants, citrus fruit and juice showed a similar trend (relative risk 0.90, 95% CI 0.77 to 1.05), they reported in the April issue of Stroke: Journal of the American Heart Association.
Vitamin C has gotten most of the praise for the protective effect of citrus found in prior stroke studies, but in Cassidy’s analysis of the Nurses’ Health Study, the vitamin didn’t correlate with total or ischemic stroke or attenuate the link to flavanones.
Most of the flavanones consumed by women in the study came from orange and grapefruit juice (63%). But eating the whole fruit would likely be a better way to boost intake, the researchers suggested.
“Given the higher flavanone content of citrus fruits and the sugar content of commercial fruit juices, public health recommendations should focus on increasing citrus fruit intake,” they recommended in the paper.
Flavanones are one of six types of commonly consumed flavonoids, which various studies have linked individually to different benefits — hypertension risk reduction with anthocyanins, lower stroke risk in some studies of flavonols — but never looked at all simultaneously.
Cassidy’s group broke down food frequency data from nearly 70,000 women participating in the Nurses’ Health Study for total flavonoid intake and for each component.
With dietary reports every four years over a total 14 years of follow-up, the researchers found big variations in total flavonoid intake, ranging from an average 761 mg per day in the top quintile to 97 mg per day in the bottom quintile.
Tea was the biggest contributor to those levels, followed by apples and oranges or orange juice. However, total flavonoid intake didn’t predict ischemic stroke risk in the multivariate-adjusted model (P=0.36 for trend).
These results suggested “that flavanones may be another important cardioprotective constituent of citrus fruits,” Cassidy’s group wrote. “However, in a population-based study like ours, it is impossible to disentangle the relative influence of all the constituents of citrus fruits.”
An impact from flavanones is plausible, they noted, pointing to experimental evidence that two flavanones, naringenin and hesperetin, act on neuroprotective pathways with effects on nitric oxide release. Naringenin was the strongest anti-inflammatory of all the flavonoids tested in one study.
A trend appeared for the flavones at the highest intake level of more than 3 mg per day compared with the lowest at less than 1 mg per day, but the difference wasn’t statistically significant (adjusted relative risk 0.88, 95% CI 0.72 to 1.08).
The same was true for anthocyanins (blueberries were the main source) and flavan-3-ols (predominantly consumed from tea). None of the compounds impacted hemorrhagic stroke risk.
Individual flavonoids are likely to differ in benefits because of different mechanisms through their specific structural characteristics, the researchers noted. They cautioned that residual or unmeasured confounding was possible despite the detailed adjustment used in the study.
Another limitation is that the actual flavonoid content in foods consumed may have differed from levels recorded because of wide variability based on where the food was grown and during what season and how it was cultivated and processed.
Randomized trials are needed to test flavanone and citrus foods for reduction of ischemic stroke risk, the group concluded.
For the first time, scientists have produced evidence in living humans that the protein tau, which mars the brain in Alzheimer’s disease, spreads from neuron to neuron. Although such movement wasn’t directly observed, the finding...
When the average person goes to the doctor, shows up at the ER, or enters the hospital, the possibility of controlling what happens next is minimal. We put ourselves...
According to the Alzheimer’s Society of Canada, 72% of Canadians living with Alzheimer’s disease are women. Is that because of their biological sex at birth? Does it have to do with the fact that...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.